Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
‘Ukrainian housewives’ and Skyranger delays – German defense poster child Rheinmetall is in hot water - 2Top 20 Compelling Business Books for Progress
- 3Instructions to Back Your Sunlight powered chargers: Tracking down Possible Choices
- 4Grasping the Basics of Business Land Regulation
- 55 Arising Professions in Environmentally friendly power
- Israel Police arrest twenty-one as anti-war protests grow despite broad support for Iran war
- New images reveal interstellar comet 3I/ATLAS approaching Earth
- I'm an 83-year-old yoga instructor. I'm not your typical grandma — I still work to feel fulfilled and supplement my Social Security.
- A Pompeii site reveals the recipe for Roman concrete. It contradicts a famous architect’s writings
- Vote in favor of the Web-based Work out schedule to Keep You Fit and Sound
- If evolution is real, then why isn’t it happening now? An anthropologist explains that humans actually are still evolving
- After harsh winter, Ukrainians find joy in releasing bats rescued from war
- Financial plan Cordial Home Redesigns That Add Worth
- State asks High Court to reject challenge to anti-UNRWA laws ahead of Monday hearing
